Efficacy of Lavender Essential Oil Chest Wraps in Infants With Bronchiolitis

Last updated: March 25, 2025
Sponsor: University Hospital, Geneva
Overall Status: Active - Recruiting

Phase

4

Condition

Respiratory Syncytial Virus (Rsv) Infection

Bronchitis (Pediatric)

Treatment

Control

Lavender essential oil 10%, diluted in 90% olive oil

Clinical Study ID

NCT06108648
2022-01116
  • Ages < 11
  • All Genders

Study Summary

The goal of this clinical trial is to learn if lavender essential oil chest wraps relieve cough in infants with bronchiolitis compared to standard care. Furthermore, the researchers will evaluate if breathing difficulties, nighttime awakening and impact on parents will be improved by the lavender oil chest wraps. Infants will be randomized to receive standard care with the addition of lavender oil chest wraps or to receive standard care alone. The study will take place in two locations in Switzerland, at the Geneva University Hospital and the Fribourg Cantonal Hospital.

Eligibility Criteria

Inclusion

Inclusion criteria:

  • Bronchiolitis: clinical diagnosis based on the combination of respiratory distress (tachypnea, grunting, nasal flaring, retractions, and/or need for supplementaryoxygen) and fine crackles sometimes accompanied by wheezing on auscultation.

  • Hospitalization.

  • Written informed consent.

Exclusion

Exclusion criteria:

  • Patients with underlying diseases that impact respiratory or heart function (congenital heart disease, congenital malformation of the lung or airway system andsevere chronic lung disease).

  • More than 3 episodes of bronchiolitis.

  • Critically ill infants who have an immediate need for intensive care unit (ICU)admission.

  • Respiratory deterioration needing Continuous positive airway pressure (CPAP) ortransfer to ICU during study enrollment.

  • Atopic dermatitis, eczema or other skin lesions (particularly on the chest).

  • Oncologic disease.

  • Premature infants with mild bronchopulmonary dysplasia will not be excluded.

Study Design

Total Participants: 400
Treatment Group(s): 2
Primary Treatment: Control
Phase: 4
Study Start date:
December 07, 2023
Estimated Completion Date:
April 30, 2026

Connect with a study center

  • Clinique de pediatrie, HFR Fribourg - Hopital cantonal, Switzerland

    Fribourg, 1708
    Switzerland

    Active - Recruiting

  • Children's' Hospital, University Hospital of Geneva, Switzerland

    Geneva, 1211
    Switzerland

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.